3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Dendritic Cell Sarcoma, Interdigitating
1
Interventions
Cyclophosphamide
139
Rituximab
115
Etoposide
77
Vincristine
75
Doxorubicin
62
Cytarabine
61
Dexamethasone
58
Prednisone
55
fludarabine
52
Methotrexate
46
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
42
Lenalidomide
37
Gemcitabine
35
Radiotherapy
29
Melphalan
27
pegaspargase
22
Prednisolone
22
Ifosfamide
22
fludarabine phosphate
20
Busulfan
20
Cisplatin
19
Bendamustine Hydrochloride
19
Asparaginase
18
Peripheral Blood Stem Cell Transplantation
17
ibrutinib
16
Decitabine
16
Carmustine
16
Mercaptopurine
15
Filgrastim
15
Oxaliplatin
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Activities of Daily Living
×
Lymphoid
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled